News | Stroke | October 18, 2019

New Algorithm Expands Neurologists' Ability to Assess for Clot-removing Procedure

Researchers use artificial intelligence CT angiograms, a more readily available test, to analyze portions of the brain affected by ischemic stroke

New Algorithm Expands Neurologists' Ability to Assess for Clot-removing Procedure

October 18, 2019 — An algorithm developed by faculty at The University of Texas Health Science Center at Houston (UTHealth) can help physicians outside of major stroke treatment centers assess whether a patient suffering from ischemic stroke would benefit from an endovascular procedure to remove a clot blocking an artery.

Results of their clinical study using the algorithm were published online in the journal Stroke.[1]

Endovascular thrombectomy is a procedure that involves threading a catheter through the femoral artery in the leg all the way to the brain, where the clot can be removed mechanically. Since 2015, studies have shown it can improve outcomes for stroke patients, but only if the amount of brain tissue that has been injured is minimal at the time of treatment.

Unfortunately, advanced neuroimaging to detect within hours whether a patient is a candidate for the treatment is limited to emergent magnetic resonance imaging (MRI) or computed tomography (CT) perfusion. That kind of technology and expertise are not available at most community hospitals and primary stroke centers.

“With endovascular thrombectomy, we now have a treatment for ischemic stroke that is really revolutionary. It allows us to take stroke patients from severe disability and return them to an almost normal life,” said Sunil A. Sheth, M.D., corresponding author and assistant professor of neurology with McGovern Medical School at UTHealth. “Unfortunately, the advanced imaging techniques used currently to identify which patients benefit from this procedure are not widely available outside of large referral hospitals. As a result, most stroke patients don’t have access to guideline-based screening for these treatments.”

In response, Sheth and Luca Giancardo, Ph.D., senior author and assistant professor at UTHealth School of Biomedical Informatics, developed a machine learning tool that could be used with a widely available imaging technique, CT angiogram. The tool can analyze images by automatically “learning” subtle image patterns that can be used as a proxy for other more advanced, but not readily available, imaging modalities such as CT perfusion. The machine learning architecture, called DeepSymNet, was developed at UTHealth.

To test the tool, the research team identified patients in their stroke registry who had suffered a stroke or had conditions that mimicked stroke.

Of the 224 who had stroke, 179 had cerebral blood vessels that were blocked. The DeepSymNet algorithm learned to identify these blockages from the CT angiogram images, and trained the software to use those same images to define the area of brain that had died, using concurrent acquired CT perfusion scans as the “gold standard.”

“The advantage is you don’t have to be at an academic health center or a tertiary care hospital to determine whether this treatment would benefit the patient. And best of all, CT angiogram is already widely used for patients with stroke,” Sheth said.

For more information: www.ahajournals.org/journal/stroke

Reference

1. Sheth S.A., Lopez-Rivera V., Barman A., et al. Machine Learning–Enabled Automated Determination of Acute Ischemic Core From Computed Tomography Angiography. Stroke, published online Sept. 24, 2019. https://doi.org/10.1161/STROKEAHA.119.026189


Related Content

News | Stroke

May 28, 2025 — Siemens Healthineers has introduced the first mobile stroke unit (MSU) featuring the Somatom On.site head ...

Home May 28, 2025
Home
News | Stroke

May 21, 2025 — RapidAI recently announced new study findings that show RapidAI’s clinically deep algorithms deliver ...

Home May 21, 2025
Home
News | Stroke

April 17, 2025 — Adults younger than 50 years of age had more than double the risk of having a stroke from migraine or ...

Home April 17, 2025
Home
News | Stroke

On April 9, 2025, the world’s first multisector advocacy movement dedicated to stroke — the Global Stroke Action ...

Home April 15, 2025
Home
News | Stroke

March 3, 2025 — Genentech, a member of the Roche Group, recently announced that the U.S. Food and Drug Administration ...

Home March 04, 2025
Home
News | Stroke

Feb. 6, 2025 — New findings from the DiVERT Stroke clinical study showed women spent less time in the hospital, saw ...

Home February 07, 2025
Home
News | Stroke

Feb. 5, 2025 — Removing a clot blocking a medium- or small-sized artery in the brain mechanically is a safe treatment ...

Home February 07, 2025
Home
News | Stroke

Jan. 29, 2025 — Researchers at Ochsner Health, led by Hernan Bazan, MD, DFSVS, FACS, have developed a predictive model ...

Home January 30, 2025
Home
News | Stroke

Nov. 16, 2024 Anthos Therapeutics, Inc.recently presented new data at the American Heart Association (AHA) Scientific ...

Home November 18, 2024
Home
News | Stroke

Oct. 24, 2024 – Royal Philips and Medtronic Neurovascular have announced a strategic advocacy partnership. Delivering ...

Home October 24, 2024
Home
Subscribe Now